[go: up one dir, main page]

BR0308184A - Composição oftálmica compreendendo ascomicina - Google Patents

Composição oftálmica compreendendo ascomicina

Info

Publication number
BR0308184A
BR0308184A BR0308184-2A BR0308184A BR0308184A BR 0308184 A BR0308184 A BR 0308184A BR 0308184 A BR0308184 A BR 0308184A BR 0308184 A BR0308184 A BR 0308184A
Authority
BR
Brazil
Prior art keywords
ascomycin
ophthalmic composition
ophthalmic
blepharitis
treatment
Prior art date
Application number
BR0308184-2A
Other languages
English (en)
Inventor
Maggy Babiole Saunier
Jean-Claude Bizec
Michelle Pik-Han Wong
Shau-Fong Yen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308184(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0308184A publication Critical patent/BR0308184A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"COMPOSIçãO OFTáLMICA COMPREENDENDO ASCOMICINA". A presente invenção refere-se às composições oftálmicas tópicas compreendendo uma ascomicina, por exemplo para o tratamento de doenças inflamatórias, tais como a blefarite.
BR0308184-2A 2002-03-04 2003-03-03 Composição oftálmica compreendendo ascomicina BR0308184A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US40927502P 2002-09-09 2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en) 2002-03-04 2003-03-03 Ophthalmic composition comprising ascomycin

Publications (1)

Publication Number Publication Date
BR0308184A true BR0308184A (pt) 2005-01-11

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308184-2A BR0308184A (pt) 2002-03-04 2003-03-03 Composição oftálmica compreendendo ascomicina

Country Status (27)

Country Link
US (4) US20050220823A1 (pt)
EP (1) EP1482936B1 (pt)
JP (1) JP4740542B2 (pt)
KR (1) KR100992948B1 (pt)
CN (1) CN1297270C (pt)
AR (1) AR038628A1 (pt)
AT (1) ATE341326T1 (pt)
AU (1) AU2003218679B2 (pt)
BR (1) BR0308184A (pt)
CA (1) CA2477769C (pt)
CO (1) CO5611133A2 (pt)
DE (1) DE60308836T2 (pt)
DK (1) DK1482936T3 (pt)
EC (1) ECSP045277A (pt)
EG (1) EG24403A (pt)
ES (1) ES2274214T3 (pt)
IL (2) IL163657A0 (pt)
MX (1) MXPA04008571A (pt)
MY (1) MY137563A (pt)
NO (1) NO20044092L (pt)
NZ (1) NZ534690A (pt)
PE (1) PE20030828A1 (pt)
PL (1) PL210870B1 (pt)
PT (1) PT1482936E (pt)
RU (1) RU2322982C2 (pt)
TW (1) TW200305437A (pt)
WO (1) WO2003074054A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE382330T1 (de) 2002-07-15 2008-01-15 Alcon Inc Nichtpolymere lipophile pharmazeutische implantat-zusammensetzungen für die intraokulare anwendung
BR0312817A (pt) * 2002-07-23 2005-04-19 Novartis Ag Composição de pomada oftálmica compreendendo uma droga, uma base de pomada e um agente solubilizante/dispersante
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en) 2009-04-09 2010-10-13 Nestec S.A. Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
ES2547556T3 (es) * 2009-05-12 2015-10-07 Galenica Ab Emulsión de aceite en agua de mometasona y propilenglicol
CN102655858B (zh) * 2009-12-22 2015-11-25 Abbvie公司 Abt-263胶囊
RU2437647C2 (ru) * 2010-02-27 2011-12-27 Пшеничников Виталий Георгиевич Фармацевтическая композиция, обладающая антибактериальным, противовирусным и противогрибковым действием
AU2011237689A1 (en) * 2010-04-07 2012-11-08 Allergan, Inc. Combinations of preservatives for ophthalmic compositions
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
AU2013384818A1 (en) * 2013-03-27 2015-11-12 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
US11103464B2 (en) * 2013-11-29 2021-08-31 Rohto Pharmaceutical Co., Ltd. Aqueous composition for ophthalmological use or otolaryngological use
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
TW202432089A (zh) * 2023-01-31 2024-08-16 溫士頓醫藥股份有限公司 一種滴眼油劑型的醫藥組合物
CN121263183A (zh) 2023-04-06 2026-01-02 普利马克制药有限责任公司 吡美莫司用于治疗患者的特征在于牛津分级量表角膜染色评分为4或5分的干眼症的用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0406791T3 (da) * 1989-07-05 1995-03-27 Fujisawa Pharmaceutical Co Vandigt flydende præparat til ekstern anvendelse
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
CA2142103C (en) * 1992-08-28 2003-07-08 Haim Aviv Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
ES2152329T3 (es) * 1993-08-18 2001-02-01 Alcon Lab Inc Composiciones derivadas de ergolina para el tratamiento del glaucoma.
WO1996011003A1 (en) * 1994-10-10 1996-04-18 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
PT786986E (pt) * 1994-10-26 2002-07-31 Novartis Ag Formulacoes farmaceuticas
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
ES2284248T3 (es) * 1998-04-27 2007-11-01 Astellas Pharma Inc. Formulacion farmaceutica en gel que comprende un compuesto triciclico (fk-506/tacrolimus).
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
TWI230066B (en) * 1999-04-30 2005-04-01 R Tech Ueno Ltd A pharmaceutical composition for treating dry eye

Also Published As

Publication number Publication date
CO5611133A2 (es) 2006-02-28
WO2003074054A1 (en) 2003-09-12
HK1071301A1 (en) 2005-07-15
NO20044092L (no) 2004-09-27
IL163657A (en) 2009-11-18
DE60308836T2 (de) 2007-04-26
KR20040094718A (ko) 2004-11-10
PE20030828A1 (es) 2003-11-04
RU2322982C2 (ru) 2008-04-27
ES2274214T3 (es) 2007-05-16
CN1297270C (zh) 2007-01-31
MXPA04008571A (es) 2004-12-06
JP4740542B2 (ja) 2011-08-03
EP1482936B1 (en) 2006-10-04
ATE341326T1 (de) 2006-10-15
CA2477769C (en) 2011-01-18
ECSP045277A (es) 2004-10-26
TW200305437A (en) 2003-11-01
AR038628A1 (es) 2005-01-19
DE60308836D1 (de) 2006-11-16
US20100113501A1 (en) 2010-05-06
EP1482936A1 (en) 2004-12-08
PT1482936E (pt) 2007-01-31
KR100992948B1 (ko) 2010-11-08
US20120015971A1 (en) 2012-01-19
CN1638769A (zh) 2005-07-13
RU2004129593A (ru) 2005-09-10
US20050220823A1 (en) 2005-10-06
PL370917A1 (en) 2005-06-13
MY137563A (en) 2009-02-27
US20110152307A1 (en) 2011-06-23
IL163657A0 (en) 2005-12-18
NZ534690A (en) 2007-06-29
JP2005529851A (ja) 2005-10-06
CA2477769A1 (en) 2003-09-12
EG24403A (en) 2009-04-29
AU2003218679A1 (en) 2003-09-16
DK1482936T3 (da) 2007-01-08
PL210870B1 (pl) 2012-03-30
AU2003218679B2 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
BR0308184A (pt) Composição oftálmica compreendendo ascomicina
BRPI0512683A (pt) compostos anti-virais
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
ES2183937T3 (es) Inhibidores de la adhesion celular.
BRPI0408369A (pt) derivados de indol úteis para o tratamento de doenças
TW200716596A (en) Substituted amide derivatives and methods of use
DE60325379D1 (de) Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
TNSN06228A1 (en) Compounds and methods of use
MXPA05012025A (es) Imidazo y tiazolopiridinas como inhibidores de cinasa jak3.
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
BR0313397A (pt) Inibidores de proteina cinase e usos destes
SE0301010D0 (sv) Novel compounds
CR8649A (es) Derivados de formamidina para el tratamiento de enfermedades
ATE490788T1 (de) Antivirale phosphonate analoge
ATE433447T1 (de) Pyrimiidinverbindungen
MA32811B1 (fr) Nouveaux composés
SE0301009D0 (sv) Novel compounds
ECSP088923A (es) Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias
TW200631583A (en) Substituted pteridines for the treatment of inflammatory diseases
BRPI0413180A (pt) gorduras de baixo teor de ácido trans-groxo e composições de gorduras, e métodos de fazer as mesmas
UA85559C2 (en) Aminobenzophenone compounds
UY28144A1 (es) Agentes terapéuticos
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
TW200505862A (en) 2-amino-pyridine derivatives useful for the treatment of diseases
CR20230485A (es) Derivados de fósforo como nuevos inhibidores de sos1

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA:INT.CI.A61K 31/436, A61K 47/14, A61K 47/44, A61K 31/4353, A61P 27/02

Ipc: A61K 31/436 (2011.01), A61K 47/14 (2011.01), A61K

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014.